Sanofi earns slump in Q3 as competition heats up
Linkedin

Sanofi earns slump in Q3 as competition heats up

Seattle : WA : USA | Oct 25, 2012 at 2:11 AM PDT
Source: Seattle Post Intelligencer
XX XX
Views: Pending
 
Sanofi says earnings slumped in the third quarter as generic competitors ate into profits of its Eloxatin cancer treatment. The French drug maker reported net profit of 1.6 billion ($2.1 billion) for the July-September quarter, down 20 percent from 2 billion a year earlier. FULL ARTICLE AT Seattle Post Intelligencer
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.